scPharmaceuticals Inc. (SCPH) DCF Valuation

scPharmaceuticals Inc. (SCPH) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

scPharmaceuticals Inc. (SCPH) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our scPharmaceuticals Inc. (SCPH) DCF Calculator enables you to evaluate scPharmaceuticals' valuation using real-world financial data and provides complete flexibility to modify all essential parameters for more accurate projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 13.6 13.6 13.6 13.6 13.6 13.6
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -30.9 -29.2 -25.0 -33.1 -46.1 8.2 8.2 8.2 8.2 8.2
EBITDA, % 100 100 100 100 -338.86 60 60 60 60 60
Depreciation .4 .4 .4 .5 .6 11.0 11.0 11.0 11.0 11.0
Depreciation, % 100 100 100 100 4.61 80.92 80.92 80.92 80.92 80.92
EBIT -31.2 -29.6 -25.5 -33.5 -46.7 8.2 8.2 8.2 8.2 8.2
EBIT, % 100 100 100 100 -343.46 60 60 60 60 60
Total Cash 72.8 105.3 75.5 118.4 76.0 13.6 13.6 13.6 13.6 13.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .3 .0 .0 .0 4.5
Account Receivables, % 100 100 100 100 33.02
Inventories 2.4 .0 .0 1.2 8.8 12.6 12.6 12.6 12.6 12.6
Inventories, % 100 100 100 100 65.03 93.01 93.01 93.01 93.01 93.01
Accounts Payable 1.1 1.7 .5 1.5 4.0 11.7 11.7 11.7 11.7 11.7
Accounts Payable, % 100 100 100 100 29.43 85.89 85.89 85.89 85.89 85.89
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 -0.29427 -0.05885382 -0.05885382 -0.05885382 -0.05885382 -0.05885382
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -32.6 -31.6 -27.7 -34.2 -46.7 8.2 8.2 8.2 8.2 8.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -33.8 -28.0 -28.4 -34.0 -55.7 15.7 19.1 19.1 19.1 19.1
WACC, % 8.85 8.85 8.85 8.85 8.85 8.85 8.85 8.85 8.85 8.85
PV UFCF
SUM PV UFCF 71.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 20
Terminal Value 285
Present Terminal Value 186
Enterprise Value 258
Net Debt -7
Equity Value 265
Diluted Shares Outstanding, MM 39
Equity Value Per Share 6.87

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real SCPH financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effects of your inputs on scPharmaceuticals' valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • 🔍 Real-Life SCPH Financials: Pre-filled historical and projected data for scPharmaceuticals Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate scPharmaceuticals’ intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize scPharmaceuticals’ valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review pre-entered scPharmaceuticals Inc. (SCPH) data (historical and projected).
  3. Step 3: Adjust key assumptions (yellow cells) based on your analysis.
  4. Step 4: View automatic recalculations for scPharmaceuticals Inc. (SCPH)'s intrinsic value.
  5. Step 5: Use the outputs for investment decisions or reporting.

Why Choose This Calculator for scPharmaceuticals Inc. (SCPH)?

  • All-in-One Solution: Features DCF, WACC, and financial ratio analyses tailored for scPharmaceuticals Inc. (SCPH).
  • Flexible Variables: Modify the yellow-highlighted cells to explore different financial scenarios.
  • In-Depth Analysis: Automatically determines scPharmaceuticals Inc. (SCPH)'s intrinsic value and Net Present Value.
  • Ready-to-Use Data: Comes with historical and projected data for reliable analysis.
  • High-Quality Standards: Perfect for financial analysts, investors, and business advisors focused on scPharmaceuticals Inc. (SCPH).

Who Should Use This Product?

  • Investors: Accurately estimate scPharmaceuticals Inc.'s (SCPH) fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to scPharmaceuticals Inc. (SCPH).
  • Consultants: Quickly customize the template for valuation reports tailored to scPharmaceuticals Inc. (SCPH) clients.
  • Entrepreneurs: Gain insights into financial modeling practices employed by leading pharmaceutical companies.
  • Educators: Use it as a teaching resource to illustrate valuation methodologies relevant to scPharmaceuticals Inc. (SCPH).

What the Template Contains

  • Preloaded SCPH Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.